Skip to content

Released Mar 15, 2024, before the open

10-K filed Mar 29, 2024, 89 days after period end · 0000868278-24-000004

Q4 2023 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net Income-$8.75MderivedN/M vs Q4 2022N/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived-$3,739,000N/M
Operating Incomederived-$10,959,000N/M
Operating Cash Flowderived-$753,000N/M
Free Cash Flowderived-$992,000N/M

What the release said

The release

Same quarter

MetricQ4 2023derived from reported figuresQ4 2022derived from reported figuresQ4 2021derived from reported figuresQ4 2020derived from reported figures
Revenue—$21.82M$45.16M$5.16M
Net Income-$8.75M-$2.45M$10.59M-$978.00K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR